Skip to main content
. 2022 Nov 14;23:363. doi: 10.1186/s12882-022-02994-2

Table 2.

Differences between patients with and without probable cognitive impairments in self-reported outcomes

Total (N = 305) Probable CIs (N = 70) No CI (N = 235) t-test
Mean (SD) p value Cohen's d
Disease self-efficacy 6.06 (1.84) 5.08 (1.92) 6.35 (1.72)  < .001** 0.72
Treatment self-efficacy 7.06 (1.62) 6.25 (1.68) 7.30 (1.52)  < .001** 0.68
Skills and technique acquisition 2.79 (0.41) 2.63 (0.47) 2.84 (0.37) .001** 0.52
Self-monitoring and insight 3.05 (0.38) 2.95 (0.40) 3.09 (0.37) .011* 0.35
Health services navigation 2.98 (0.41) 2.86 (0.42) 3.02 (0.40) .005** 0.39
Medication adherence 3.46 (0.76) 3.27 (0.75) 3.52 (0.76) .018* 0.33
Renal adherence behaviour questionnaire 91.99 (11.94) 89.75 (11.88) 92.65 (11.91) .074 0.24
 Fluid restrictions 38.53 (6.02) 37.66 (5.65) 38.79 (6.11) .170 0.19
 Potassium/phosphate restrictions 19.94 (2.87) 19.51 (3.19) 20.06 (2.76) .192 0.19
 Self-care 6.90 (2.09) 6.87 (1.98) 6.90 (2.12) .902 0.02
 Times of particular difficulty 19.00 (3.27) 18.16 (3.08) 19.25 (3.30) .014* 0.34
 Sodium restrictions 7.58 (1.78) 7.54 (1.85) 7.59 (1.76) .861 0.02
Depressive symptoms 8.32 (4.17) 11.04 (3.82) 7.51 (3.92)  < .001** 0.91
Anxious symptoms 7.10 (4.52) 10.31 (4.50) 6.13 (4.07)  < .001** 1.00

CI Cognitive impairments, SD Standard deviation

* p < .050

** p < .010